Valiant Organics · NSE: VALIANTORG · BSE: 540145

Q4 FY23 results · Jan–Mar 2023

Valiant Organics reported revenue from operations of ₹271.40 crore (down 21.9% from Q4 FY22) and net profit of ₹34.00 crore (down 8.3% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations271.40347.62−21.9%250.37+8.4%
Other income2.792.25+23.7%1.45+92.5%
Total income274.19349.88−21.6%251.81+8.9%
Profit before tax44.1049.13−10.2%34.69+27.1%
Net profit for the period34.0037.07−8.3%26.08+30.4%
Attributable to shareholders of the company29.7631.10−4.3%21.97+35.5%
EPS, basic (₹)10.9611.45−4.3%8.09+35.5%
Net margin (%)12.510.710.4
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations227.17290.57−21.8%217.56+4.4%
Other income0.620.96−36.2%0.66−7.4%
Total income227.78291.53−21.9%218.22+4.4%
Profit before tax34.2836.31−5.6%24.50+39.9%
Net profit for the period26.1927.18−3.6%18.51+41.5%
EPS, basic (₹)9.6410.01−3.6%6.82+41.4%
Net margin (%)11.59.48.5
Consolidated
Filed with BSE
22 May 2023, 13:11 IST
Board meeting
19 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
22 May 2023, 13:11 IST
Board meeting
19 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE